The ADV Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of adenovirus antigen (ADV) directly from nasal/throat/nasopharyngeal swabs.
It is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute Adenovirus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.
Introduction The ADV Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of adenovirus and can give a result in 15 minutes by minimally skilled personnel without any laboratory equipment.
Product specification
Product Name:ADV Antigen Rapid Test
Sample Type:Nasal Swab & Throat Swab
Loading Volume:3 drops(100ul)
Reaction Time:15 mins
Shelf Life:24 months
Storage:36-86°F (2-30℃)
Unit:25 kits/box
No need for refrigerated transportation
Advantages
Rapid : Results in 15 mins
Non-invasive diagnosis : Nasal Swab & Throat Swab
Easy & Convenient : Easy operation and no need for extra equipment
Room temperature to store
Test Procedure The test should be operated at room temperature 59-86°F(15-30℃) 1. Ready: Remove the foil from the top of the extraction buffer tube. 2. The extraction of specimen: Put the swab that had collected specimen into the extraction tube, hold and press the swab head against the wall of the tube with force and swirl for 20 seconds. Then rotate 5-7 times while squeezing the swab to release the antigen into the extraction solution from the swab head. 3. Removing swab: Squeeze the swab head firmly while removing the swab in order to remove as much liquid as possible from the swab. Dispose of swabs according to biohazard waste disposal regulations. 4. Mixing the Solution: Install the nozzle cap firmly onto the extraction tube and mix thoroughly by swirling or flicking the bottom of the extraction tube. 5. Loading: drip 3 drops of the extraction solution into the sample well of the test cartridge, and start the timer. 6. Reading Results: Read the results in 15 minutes. If the positive signal appears after 30 minutes, it should not be reported as positive.
TSH Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the thyroid stimulating hormone concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
IL-6 is a valuable biomarker for early detection and monitoring of inflammatory conditions, particularly in the context of bacterial infections and sepsis.
IL-6 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Interleukin-6 (IL-6) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.
HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.
Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.